Global Newswire by Notified: M&A

JULY 2, 2024

July 02, 2024 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. PALO ALTO, Calif., a Cayman Islands corporation and special purpose acquisition company (Nasdaq: DECA, “SPAC”), today announced the signing of a letter of intent for a proposed business combination, which provides for a pre-transaction equity value of Semnur up to $2.0

Pharmaceutical 72

Pharmaceutical Acquisitions Capital Business 72

TM Capital

JULY 17, 2024

Josh Mastracci has joined TM Capital as a Director in the firm’s Healthcare practice. Josh has extensive experience completing transactions across key healthcare services sectors including physician practice management, ambulatory surgery centers, and pharmaceutical services. Josh holds a B.A. in Economics from Boston College, a J.D.

Capital 52

Capital Pharmaceutical Private Equity Healthcare 52

PE Hub

JANUARY 8, 2024

Based in San Diego and Woburn, Massachusetts, NIS is a provider of cryo-electron microscopy services to the pharmaceutical and biotechnology communities. The post Ampersand Capital-backed NanoImaging Services appoints Rigg as CEO appeared first on PE Hub.

Capital 64

Capital Pharmaceutical Electronics 64

Global Newswire by Notified: M&A

AUGUST 3, 2023

03, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with rare diseases of the immune system, today announced the closing of a $115 million loan facility with Hercules Capital, Inc. BOSTON, Aug. NYSE: HTGC) (“Hercules”).

Pharmaceutical 40

Pharmaceutical Capital IT 40

Sun Acquisitions

JUNE 17, 2025

Healthcare Manufacturing Stands Out Two subsectors— Pharmaceutical Manufacturing and Medical Devices & Supplies —are drawing particularly deep interest. Examples of Recent Transactions Select deals that exemplify this trend include: SK Capital Partners acquired Spectrum Vascular , a vascular access device firm.

Private Equity 52

Private Equity Manufacturing Equities Architecture 52

Global Newswire by Notified: M&A

SEPTEMBER 21, 2023

21, 2023 (GLOBE NEWSWIRE) -- Gurnet Point Capital (“Gurnet Point”) and Novo Holdings A/S (“Novo Holdings”) announced today the completion of their acquisition of Paratek Pharmaceuticals, Inc. CAMBRIDGE, Mass.,

Pharmaceutical 40

Pharmaceutical Capital Acquisitions 40

Global Newswire by Notified: M&A

FEBRUARY 5, 2025

LONDON and BOSTON and TUSTIN, Calif., LONDON and BOSTON and TUSTIN, Calif.,

Capital 40

Capital Private Equity Healthcare Pharmaceutical 40

Global Newswire by Notified: M&A

AUGUST 21, 2023

21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. WARREN, NJ, Aug. Timber” or the “Company”) (NYSE American: TMBR) today announced that it has entered into a definitive agreement to be acquired by LEO US Holding, Inc. (“LEO

Pharmaceutical 40

Pharmaceutical Stock Shares Equities 40

Growth Business

OCTOBER 2, 2023

By Tim Bird on Growth Business - Your gateway to entrepreneurial success It was a buoyant 2018 for venture capital investment into UK and European companies – a trend which defied broader concerns about international trade tensions, economic growth prospects and, of course, Brexit.

Finance 52

Finance Finance Capital Funds 52

Private Equity Info

JUNE 9, 2025

Our M&A database has tracked more than 1,060 manufacturing-focused transactions in 24 months , giving us a front-row seat to where capital is flowing, and more importantly, why. Sample Transactions Medical Equipment and Supplies Manufacturing SK Capital Partners acquired Spectrum Vascular ( White Plains, NY ).

Private Equity 52

Private Equity Equities Manufacturing Medical 52

Global Newswire by Notified: M&A

JUNE 6, 2023

Transaction Provides Paratek Shareholders with Immediate Value and Liquidity Reflects Potential Value of $3.00 per Share of Common Stock, Including.

Pharmaceutical 40

Pharmaceutical Capital Stock Shares 40

OfficeHours

JANUARY 26, 2024

Private equity players have to face reality at some point,” said Per Franzen, head of private capital for Europe and North America at EQT AB. They need to invest remaining capital and go back to the market to raise new funds, which means a need to drive exits and improve distributions.” Have you received word on your bonus yet?

Private Equity 130

Private Equity Equities Mergers and Acquisitions M&A 130

Growth Business

NOVEMBER 21, 2023

By Timothy Adler on Growth Business - Your gateway to entrepreneurial success What kind of startups are venture capital trusts (VCTs) looking to invest in during the coming year? Brexit, Covid, Brexit, the cost-of-living crisis and the end of cheap capital have all created strong headwinds for VCT fundraising. What is a VCT?

Investment 59

Investment Capital Business Management 59

InvestmentBank.com

AUGUST 14, 2019

According to Holon IQ, the global education market has reached a value of over $6 trillion with only $150 billion of market capitalization. The benefits of VR are not limited to language immersion, architecture, interior design, space expedition, biology, chemistry or pharmaceutical practices.

Education 52

Education Mergers and Acquisitions Capital Investment 52

The Risk Arbitrage Report

NOVEMBER 27, 2022

Smith Financial Corp to acquire Home Capital Group Inc Com (HMCBF). Closed Deals: • Alcon Ag Com (ALC) completes acquisition of Aerie Pharmaceuticals Inc Csh Mrg @$15.25/Sh New Deals: • Merck & Co Inc Com (MRK) to acquire Imago Biosciences Inc Com (IMGO). Paine Schwartz Partners to acquire Agrofresh Solutions Inc Com (AGFS).

Pharmaceutical 40

Pharmaceutical Acquisitions Capital Management 40

Global Newswire by Notified: M&A

DECEMBER 7, 2023

Following the Acquisition, it is contemplated that SciSparc shareholders will hold approximately 50.01% of the share capital of the post-closing combined company (the “Combined Company”), compared to 20%, as reflected in the previous announcement. TEL AVIV, Israel, Dec. 07, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd.

Negotiation 45

Negotiation Pharmaceutical Acquisitions Capital 45

Global Newswire by Notified: M&A

OCTOBER 16, 2024

PALO ALTO, Calif., Nasdaq: DECA) for a pre-transaction equity value of $2.5 billion which transaction is expected to occur by the end of fourth quarter of 2024 or the first quarter of 2025.

Equities 45

Equities Business Pharmaceutical Capital 45

Cooley M&A

OCTOBER 19, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals. Drinks With The Deal’: Cooley’s Ian Nussbaum Talks Case Law.

M&A 69

M&A Initial Public Offering Pharmaceutical Medical 69

Cooley M&A

JANUARY 22, 2020

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 2019 was a banner year for billion-dollar life sciences M&A transactions.

M&A 40

M&A Pharmaceutical Acquisitions Capital 40

The Risk Arbitrage Report

NOVEMBER 20, 2022

New Deals: • Indivior Plc Com (IZQVF) to acquire Opiant Pharmaceuticals Inc Com (OPNT). Wood Capital Advisors completes acquisition of Stealth Biotherapeutics Corp Csh Mrg $0.375/Sh 11/16/22 (MITO). Washington Federal Inc Com (WAFD) to acquire Luther Burbank Corporation Com (LBC). Sh 11/15/22 (CSVI). Sh 11/15/22 (ECOM).

Pharmaceutical 40

Pharmaceutical Acquisitions Corporation Capital 40

The Risk Arbitrage Report

SEPTEMBER 18, 2022

Searchlight Capital Partners completes acquisition of Hemisphere Media Group Inc Csh Mrg $7.00/Sh Syros Pharmaceuticals Inc 1:10 R/S 9/19/22 87184Q206 (SYRS) completes acquisition of Tyme Technologies Inc.04382:1 Syros Pharmaceuticals Inc 1:10 R/S 9/19/22 87184Q206 (SYRS) completes acquisition of Tyme Technologies Inc.04382:1

Pharmaceutical 40

Pharmaceutical Acquisitions Media Corporation 40

Mergers and Inquisitions

MAY 10, 2023

The basic difference is that the international bulge bracket banks tend to be stronger in M&A advisory and weaker in equity and debt capital markets. If you focus on the capital markets , you’ll still see some of these names (e.g., Lazard also used to be active but has since shut down its Southeast Asia M&A practice.

Investment Banking 105

Investment Banking Banking Bank Investment 105

Mergers and Inquisitions

NOVEMBER 1, 2023

Healthcare Private Equity Definition : A healthcare private equity firm raises capital from outside investors (Limited Partners), acquires companies in the healthcare services, devices, and healthcare IT segments, and aims to grow these firms and sell their stakes within 3 – 7 years to realize a return on their investments.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Peak Frameworks

APRIL 29, 2024

Capital Requirements The need for substantial capital investment to enter an industry acts as a significant deterrent to new entrants. For instance, the pharmaceutical industry requires immense investment in research and development, regulatory approvals, and manufacturing capabilities.

Finance 52

Finance Finance Investment Banking Investment 52

Cooley M&A

JANUARY 23, 2024

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity.

M&A 52

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 52

Peak Frameworks

SEPTEMBER 12, 2023

A prime example is the pharmaceutical industry. Covering High Initial Costs or R&D Investments The initial stages of product development often involve high costs, especially in sectors like biotechnology, pharmaceuticals, and technology. Setting a High Initial Price Why would a company opt for a high initial price?

Pharmaceutical 52

Pharmaceutical Investment Banking Investment IT 52

The Deal

JUNE 28, 2023

From his perch on Bay Street in Toronto, Feldman offered his two cents about an activist campaign launched by MKT Capital LP seeking to remove directors at Aurinia Pharmaceuticals Inc. AUPH), even though he isn’t involved in the situation.

Investment 52

Investment Shares Pharmaceutical Investors 52

Growth Business

MAY 31, 2023

How is it different to venture capital funding? The Green Angel Syndicate, as the name suggests, focuses on climate tech and the Angel Academe focuses on female-founded start-ups. They can also differ by region and investment size. Angel investors use their own money and many have been entrepreneurs themselves, like you see on Dragons’ Den.

Investment 96

Investment Investors Funds Business 96

Cooley M&A

JANUARY 30, 2024

3] Elliott Management (15 campaigns), Starboard Value (9), Align Partners (8), ValueAct Capital (8) and Ancora (6) topped the activist leaderboard for the year, with JANA Partners and Sarissa Capital Management also highly active in the technology and healthcare sectors. [4]

Private Equity 52

Private Equity M&A Capital Investors 52

InvestmentBank.com

SEPTEMBER 18, 2019

Now Amazon truly does have more than a foot in the door to the pharmaceutical market. It is logical to think that Walmart will start making DTC pharmaceuticals a part of its push away from shopping in brick and mortar to have pick-up stations and home delivery. Walmart already has a pharmacy in every “Supercenter” location.

Food 52

Food Valuation Acquisitions M&A 52

Solganick & Co.

SEPTEMBER 2, 2024

March 2024: Clearlake Capital Group and Insight Partners complete the Acquisition of data analytics software firm Alteryx for $4.4B (announced December 2023). April 2024: PE firm Advent International completed a $6.3 billion buyout of Nuvei. Rocket Software, based in Waltham, Mass., provides IT modernization and IT automation services.

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52

Cooley M&A

FEBRUARY 8, 2018

Ideally, the revesting provisions are structured to provide key employees long-term capital gains treatment on any deferred payments (compared to the ordinary income attributed to vested options or restricted stock units cashed out at closing). The typical revesting period for these arrangements is 24 to 36 months.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

Software Equity Group

JUNE 6, 2023

As an example, Ideagen, backed by HG Capital, entered the maritime industry this May through its purchase of Tritan.  Ideagen is a leading provider of software solutions to regulated and high-compliance industries, including pharmaceutical, aerospace and defense, and life sciences.

M&A 52

M&A Mergers and Acquisitions Middle Market Acquisitions 52

Devensoft

AUGUST 22, 2023

Freelance modeling can facilitate the integration of cultures and operational processes, enabling the two entities to capitalize on each other’s strengths while retaining their distinctiveness. Consider a merger between a pharmaceutical company and a biotech startup.

M&A 52

M&A Business Mergers and Acquisitions Collaboration 52

Cooley M&A

JUNE 10, 2020

The panel kicked off with a discussion about what types of assets pharmaceutical buyers tend to gravitate toward – both from a general market perspective and from the more specific view of Horizon. Key areas of interest for buyers and investors. rheumatology, nephrology, ophthalmology and endocrinology) and diseases within those areas.

M&A 40

M&A Medical Acquisitions Business 40

Software Equity Group

AUGUST 20, 2024

Additionally, they can often capitalize on synergies between the two companies’ software solutions, creating a more comprehensive suite of offerings that attracts new customers and boosts overall revenues. The public company was founded in 1985 and is domiciled in Sweden.

Investment 52

Investment Management Acquisitions Business 52